Sun-Novo(SH:688621) Xin Lang Cai Jing·2025-09-09 02:16Company Overview - Sunshine Nuohua Pharmaceutical Research Co., Ltd. is located in Changping District, Beijing, and was established on March 9, 2009. The company went public on June 21, 2021. Its main business involves the development of generic drugs, consistency evaluation, and innovative drug development, providing comprehensive R&D services including pharmaceutical research, clinical trials, and bioanalysis [1]. Financial Performance - As of September 9, Sunshine Nuohua's stock price increased by 5.05%, reaching 83.49 CNY per share, with a trading volume of 77.2037 million CNY and a turnover rate of 0.85%. The total market capitalization stands at 9.351 billion CNY [1]. Fund Holdings - Tianhong Fund has a significant position in Sunshine Nuohua, with its Tianhong Healthcare A Fund (001558) holding 879,000 shares, accounting for 8.73% of the fund's net value, making it the third-largest holding. The estimated floating profit from this position is approximately 3.5248 million CNY [2]. Fund Manager Performance - The fund manager of Tianhong Healthcare A is Lü Qiao, who has been in the position for 251 days. The total asset size of the fund is 502 million CNY, with the best fund return during the tenure being 49.91% and the worst being 49.5% [3].